These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 19814725)

  • 21. Blood pressure-independent inhibition of Marfan aortic root widening by the angiotensin II receptor blocker valsartan.
    Tehrani AY; White Z; Milad N; Esfandiarei M; Seidman MA; Bernatchez P
    Physiol Rep; 2021 May; 9(10):e14877. PubMed ID: 34042309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vasomotor dysfunction in the thoracic aorta of Marfan syndrome is associated with accumulation of oxidative stress.
    Yang HH; van Breemen C; Chung AW
    Vascul Pharmacol; 2010; 52(1-2):37-45. PubMed ID: 19879959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered tissue behavior of a non-aneurysmal descending thoracic aorta in the mouse model of Marfan syndrome.
    Haskett D; Doyle JJ; Gard C; Chen H; Ball C; Estabrook MA; Encinas AC; Dietz HC; Utzinger U; Vande Geest JP; Azhar M
    Cell Tissue Res; 2012 Jan; 347(1):267-77. PubMed ID: 22105919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of Marfan Syndrome Aortic Root Dilation by Losartan: Role of Angiotensin II Receptor Type 1-Independent Activation of Endothelial Function.
    Sellers SL; Milad N; Chan R; Mielnik M; Jermilova U; Huang PL; de Crom R; Hirota JA; Hogg JC; Sandor GG; Van Breemen C; Esfandiarei M; Seidman MA; Bernatchez P
    Am J Pathol; 2018 Mar; 188(3):574-585. PubMed ID: 29433732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating transforming growth factor-beta in Marfan syndrome.
    Matt P; Schoenhoff F; Habashi J; Holm T; Van Erp C; Loch D; Carlson OD; Griswold BF; Fu Q; De Backer J; Loeys B; Huso DL; McDonnell NB; Van Eyk JE; Dietz HC;
    Circulation; 2009 Aug; 120(6):526-32. PubMed ID: 19635970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Losartan improves aortic endothelium-dependent relaxation via proline-rich tyrosine kinase 2/Src/Akt pathway in type 2 diabetic Goto-Kakizaki rats.
    Nemoto S; Kobayashi T; Taguchi K; Matsumoto T; Kamata K
    Am J Physiol Heart Circ Physiol; 2011 Dec; 301(6):H2383-94. PubMed ID: 21926342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lineage-Specific Induced Pluripotent Stem Cell-Derived Smooth Muscle Cell Modeling Predicts Integrin Alpha-V Antagonism Reduces Aortic Root Aneurysm Formation in Marfan Syndrome Mice.
    Nakamura K; Dalal AR; Yokoyama N; Pedroza AJ; Kusadokoro S; Mitchel O; Gilles C; Masoudian B; Leipzig M; Casey KM; Hiesinger W; Uchida T; Fischbein MP
    Arterioscler Thromb Vasc Biol; 2023 Jul; 43(7):1134-1153. PubMed ID: 37078287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced caspase activity contributes to aortic wall remodeling and early aneurysm development in a murine model of Marfan syndrome.
    Emrich FC; Okamura H; Dalal AR; Penov K; Merk DR; Raaz U; Hennigs JK; Chin JT; Miller MO; Pedroza AJ; Craig JK; Koyano TK; Blankenberg FG; Connolly AJ; Mohr FW; Alvira CM; Rabinovitch M; Fischbein MP
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):146-54. PubMed ID: 25359856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. No beneficial effect of general and specific anti-inflammatory therapies on aortic dilatation in Marfan mice.
    Franken R; Hibender S; den Hartog AW; Radonic T; de Vries CJ; Zwinderman AH; Groenink M; Mulder BJ; de Waard V
    PLoS One; 2014; 9(9):e107221. PubMed ID: 25238161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Effect of a Nonpeptide Angiotensin II Type 2 Receptor Agonist, Compound 21, on Aortic Aneurysm Growth in a Mouse Model of Marfan Syndrome.
    Verbrugghe P; Verhoeven J; Clijsters M; Vervoort D; Schepens J; Meuris B; Herijgers P
    J Cardiovasc Pharmacol; 2018 Apr; 71(4):215-222. PubMed ID: 29300219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell Type-Specific Contributions of the Angiotensin II Type 1a Receptor to Aorta Homeostasis and Aneurysmal Disease-Brief Report.
    Galatioto J; Caescu CI; Hansen J; Cook JR; Miramontes I; Iyengar R; Ramirez F
    Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):588-591. PubMed ID: 29371244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
    Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M
    Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of losartan as add-on therapy to prevent aortic growth and ventricular dysfunction in patients with Marfan syndrome: a randomized, double-blind clinical trial.
    Muiño-Mosquera L; De Nobele S; Devos D; Campens L; De Paepe A; De Backer J
    Acta Cardiol; 2017 Dec; 72(6):616-624. PubMed ID: 28657492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complement C3a/C3aR inhibition alleviates the formation of aortic aneurysm in Marfan syndrome mice.
    Zhang F; Yao K; Liu Y; Zhou M; Zhang Y; Hong S; Wu J; Zhang C
    BMC Cardiovasc Disord; 2024 Aug; 24(1):417. PubMed ID: 39127656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-6 regulates extracellular matrix remodeling associated with aortic dilation in a fibrillin-1 hypomorphic mgR/mgR mouse model of severe Marfan syndrome.
    Ju X; Ijaz T; Sun H; Lejeune W; Vargas G; Shilagard T; Recinos A; Milewicz DM; Brasier AR; Tilton RG
    J Am Heart Assoc; 2014 Jan; 3(1):e000476. PubMed ID: 24449804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent advances in understanding Marfan syndrome: should we now treat surgical patients with losartan?
    Matt P; Habashi J; Carrel T; Cameron DE; Van Eyk JE; Dietz HC
    J Thorac Cardiovasc Surg; 2008 Feb; 135(2):389-94. PubMed ID: 18242274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Redox stress in Marfan syndrome: Dissecting the role of the NADPH oxidase NOX4 in aortic aneurysm.
    Jiménez-Altayó F; Meirelles T; Crosas-Molist E; Sorolla MA; Del Blanco DG; López-Luque J; Mas-Stachurska A; Siegert AM; Bonorino F; Barberà L; García C; Condom E; Sitges M; Rodríguez-Pascual F; Laurindo F; Schröder K; Ros J; Fabregat I; Egea G
    Free Radic Biol Med; 2018 Apr; 118():44-58. PubMed ID: 29471108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dysfunction of endothelial and smooth muscle cells in small arteries of a mouse model of Marfan syndrome.
    Syyong HT; Chung AW; Yang HH; van Breemen C
    Br J Pharmacol; 2009 Nov; 158(6):1597-608. PubMed ID: 19814726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of elastin deficit in a Marfan mouse aneurysm model using an elastin-specific magnetic resonance imaging contrast agent.
    Okamura H; Pisani LJ; Dalal AR; Emrich F; Dake BA; Arakawa M; Onthank DC; Cesati RR; Robinson SP; Milanesi M; Kotek G; Smit H; Connolly AJ; Adachi H; McConnell MV; Fischbein MP
    Circ Cardiovasc Imaging; 2014 Jul; 7(4):690-6. PubMed ID: 24814820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resveratrol Inhibits Aortic Root Dilatation in the Fbn1C1039G/+ Marfan Mouse Model.
    Hibender S; Franken R; van Roomen C; Ter Braake A; van der Made I; Schermer EE; Gunst Q; van den Hoff MJ; Lutgens E; Pinto YM; Groenink M; Zwinderman AH; Mulder BJ; de Vries CJ; de Waard V
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1618-26. PubMed ID: 27283746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.